Ocugen

About:

Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.

Website: http://ocugen.com

Twitter/X: Ocugen

Top Investors: Avenue Capital Group, ROTH Capital Partners, Abdi Ibrahim Pharmaceuticals, EB5 Life Sciences, Lancaster Group

Description:

Ocugen is a clinical-stage biopharmaceutical company focused on discoverinOcugen Inc is a clinical-stage biopharmaceutical business focused on discovering, developing, and commercializing gene treatments to cure blinding illnesses, as well as developing a COVID-19 vaccine to save lives. The biologic product candidate aims to provide better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy using the breakthrough modifier gene therapy platform.